patient groups
Patients/ Views & Analysis/ Views and analysis
New study reveals patients’ changing needs during COVID-19
mike.hammerton@pharmaphorum.com
coronavirus, COVID-19, patient groups, patient organisations, Patients Association
0 Comment
Patients/ Views & Analysis/ Views and analysis
Education as the solution to the rare disease ‘diagnostic odyssey’
Amanda Barrell
patient groups, patient organisations, scleroderma
0 Comment
Digital/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis
BMS launches digital Advocacy Exchange for patient groups affected by COVID-19
George Underwood
BMS, Bristol-Myers Squibb, coronavirus, COVID-19, Digital Health & COVID-19, Gryt Health, patient groups, patient organisations, Pharma’s Digital Response to COVID-19
0 Comment
Industry and patient groups collaborate on new guidance for interaction
George Underwood
comms, IAPO, IFPMA, patient groups, patient organisations
0 Comment
Patients/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis
Bridging the gap between industry and charities: Enabling PPI in research
Amanda Barrell
charities, patient engagement, patient groups, PPI
0 Comment
Views & Analysis/ Views and analysis
Why pharma isn’t collaborating with patient organisations as much as it should
George Underwood
Accenture, patient centricity, patient engagement, patient groups, patient organisations
0 Comment
Patients/ Views & Analysis/ Views and analysis
Building our own community for an ultra-rare disease
Mike Smith
patient groups, patient insights, ultra-rare disease
0 Comment